Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.42 USD
-0.34 (-2.89%)
Updated Apr 24, 2024 04:00 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Balance Sheet
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 742 | 624 | 546 | 165 | 151 |
Receivables | 45 | 148 | 132 | 23 | 9 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 53 | 59 | 61 | 64 | 41 |
Other Current Assets | 19 | 86 | 233 | 39 | 7 |
Total Current Assets | 859 | 917 | 973 | 290 | 209 |
Net Property & Equipment | 37 | 38 | 35 | 31 | 32 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2 | 2 | 2 | 2 | 5 |
Deposits & Other Assets | 74 | 4 | 4 | 4 | 4 |
Total Assets | 997 | 986 | 1,039 | 353 | 279 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 3 | 3 | 3 | 9 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 52 | 35 | 54 | 22 | 19 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 111 | 499 | 52 | 25 |
Total Current Liabilities | 62 | 150 | 556 | 77 | 53 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 223 | 222 | 220 | 0 | 0 |
Long-Term Debt | 30 | 0 | 0 | 180 | 179 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 60 | 0 | 6 | 3 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 375 | 405 | 817 | 295 | 271 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,555 | 1,511 | 1,442 | 1,352 | 1,229 |
Retained Earnings | -931 | -924 | -1,217 | -1,294 | -1,219 |
Other Equity | -2 | -5 | -2 | 0 | -2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 622 | 581 | 222 | 59 | 8 |
Total Liabilities & Shareholder's Equity | 997 | 986 | 1,039 | 353 | 279 |
Total Common Equity | 622 | 581 | 222 | 59 | 8 |
Shares Outstanding | 129.20 | 127.50 | 119.90 | 110.10 | 83.80 |
Book Value Per Share | 4.81 | 4.56 | 1.85 | 0.53 | 0.10 |
Fiscal Year End for Dynavax Technologies Corporation falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 742 | 720 | 682 | 652 |
Receivables | NA | 45 | 47 | 45 | 105 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 53 | 49 | 53 | 58 |
Other Current Assets | NA | 19 | 19 | 17 | 16 |
Total Current Assets | NA | 859 | 836 | 797 | 830 |
Net Property & Equipment | NA | 37 | 36 | 37 | 38 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 2 | 2 | 2 | 2 |
Deposits & Other Assets | NA | 74 | 74 | 74 | 74 |
Total Assets | NA | 997 | 973 | 936 | 970 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 5 | 3 | 3 | 7 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 52 | 47 | 37 | 33 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 5 | 4 | 4 | 51 |
Total Current Liabilities | NA | 62 | 54 | 45 | 92 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 223 | 222 | 222 | 222 |
Long-Term Debt | NA | 30 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 61 | 61 | 61 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 375 | 368 | 359 | 406 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,555 | 1,542 | 1,528 | 1,516 |
Retained Earnings | NA | -931 | -931 | -945 | -949 |
Other Equity | NA | -2 | -6 | -5 | -4 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 622 | 605 | 577 | 564 |
Total Liabilities & Shareholder's Equity | NA | 997 | 973 | 936 | 970 |
Total Common Equity | 0 | 622 | 605 | 577 | 564 |
Shares Outstanding | 129.30 | 129.20 | 128.80 | 127.70 | 128.40 |
Book Value Per Share | 0.00 | 4.81 | 4.70 | 4.52 | 4.39 |